PDL 2 2012

User Manual: PDL-2

Open the PDF directly: View PDF PDF.
Page Count: 7

DownloadPDL-2 PDL-2-2012
Open PDF In BrowserView PDF
1

Medicaid Preferred Drug Lists (PDLs) for Mental Health and Substance Abuse
Key: * = therapeutic classes or treatment category included in PDL
States have designed, approved and implemented use of "Preferred Drug Lists" (or "PDLs") as an evolved method of encouraging or emphasizing the
prescribing, dispensing and reimbursement of certain specific prescription drugs for particular categories or classes of treatment. The design of PDLs
was initiated by several individual state Medicaid programs, including Florida, Michigan and Connecticut; such lists were first approved by CMS in mid2003. As of early 2012, at least 48 states use some type of PDL.
The table below provides a summary of state practices affecting several types of drugs used in relation to mental health and substance abuse. The table
includes links to individual state PDL documents when available, to allow a detailed examination or comparison of state practices. In some states the
same or similar PDL is applied to public employee health plans or additional state-only health coverage.
Prepublication edition.
Compiled by the NCSL Health Program – February 2012
State &
Links to PDLs
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana

CNS
Stimulants
(ADD/ADHD)
*
*

Antidepressants

*

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*

*
*

*
*
*
*
*
*
*
*
*
*

Antipsychotics

Sedatives
&
Hypnotics

Anticonvulsants

Long Acting
Narcotics
(Methadone)

Bipolar
Specific
Medications

Alcohol
Abuse
Agents

Smoking
Cessation

Anxiolytics
*

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*
*
*
*
*
*
*
*
*
*

*
*

*
*
*
*

*

*
*
*
*
*
*
*
*

*

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*

*

*
*

*
*
*

*

*

*
*
*

*

*

*
*

*
*

*

*

*

2

Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
District of
Columbia

*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*
*
*
*
*
*
*

*
*
*
*
*
*

*
*
*
*
*
*

*
*

*
*

*
*
*
*
*
*

*
*
*
*
*
*

*

*

*

*
*
*
*

*
*
*
*
*
*
*
*

*
*
*
*
*1
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
State does not have or does not publish a PDL- Please see footnote for additional information
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
State does not have or does not publish a PDL- Please see footnote for additional information
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*

*
*

*

*
*
*

*

*

*

*

*
*

*

*
*
*

*
*
*

*

*

*

*
*
*

*

*
*
*

*

*

*

3

Guam
Puerto Rico
U.S. Virgin Islands

Territory does not have or does not publish a PDL
Territory does not have or does not publish a PDL
Territory does not have or does not publish a PDL

NOTES
1 - Hypnotics only

Unlike private-sector, "closed" drug formularies, preferred drug lists provide a mechanism to place specific prescription products, by brand
and/or generic name. The technique commonly includes two listed categories: “preferred” and “non-preferred.” In most cases, both brand
name and generic products may be listed as preferred. In the case of Medicaid PDLs – both preferred and non-preferred drugs are available to
patients. However, non-preferred drugs may require an additional step: 1) certification by the physician or other prescriber that the specific
brand name product is required by the patient and cannot be substituted; 2) prior approval or pre-authorization by the state agency or 3)
certification that a preferred drug was prescribed earlier and was not medically effective. In some states, preferred drugs may be subject to a
state-negotiated supplemental rebate, payable by the manufacturer to the state agency (and not affecting the individual patient.)
The inclusion (or exclusion) of a treatment class within a PDL does not in itself define whether all, most or only some drugs to treat the condition
are considered preferred.

Authors and Research
This report and 50-state data was researched and compiled by Kara Hinkley, Research Analyst, under the direction of Richard Cauchi, Program
Director, for the NCSL Health Program-Denver. It supplements and partly replaces an earlier report on State Preferred Dug Lists, by Richard
Cauchi, published in 2008 and last updated in 2010.

MEDICAID PDL LINKS:
(links were accurate as of date of publication but are subject to change by the state agency)
ALABAMA: http://www.medicaid.state.al.us/documents/program-RX/Drug_Info/3J-3l_PDL_List_Therapeutic_10-1-10.pdf (Medicaid)
ALASKA: http://hss.state.ak.us/dhcs/pdl/drug_lists_pdl/druglist.pdf (Medicaid)

4

ARIZONA: http://www.azahcccs.gov/members/Downloads/FFSformulary_members.pdf (Medicaid- Fee for-service)
ARKANSAS: https://www.medicaid.state.ar.us/internetsolution/provider/pharm/scripinfo.aspx#overview (Medicaid)
CALIFORNIA: http://files.medical.ca.gov/pubsdoco/manual/man_query.asp?wSearch=(%23filename+drugscdl*.doc+OR+%23filename+drugscdl*.zip)&wFLogo=Contract+Drugs+List&wFLogo
H=52&wFLogoW=516&wAlt=Contract+Drugs+List&wPath=N (Medicaid)
COLORADO: http://www.colorado.gov/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=ContentDisposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3D139%2F1015%2FMicrosoft+Word+-+PDL+effective+--202+143.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1251756172832&ssbinary=true (Medicaid)
CONNECTICUT: https://www.ctdssmap.com/CTPortal/Portals/0/StaticContent/Publications/CT_PDL_medicaid.pdf (Medicaid)
DELAWARE: http://www.dmap.state.de.us/information/Pharmacy/DEM%20PDL.pdf (Medicaid)
FLORIDA: http://ahca.myflorida.com/medicaid/Prescribed_Drug/pharm_thera/pdf/120229_PDL_updated_022912.pdf (Medicaid)
GEORGIA: http://dch.georgia.gov/vgn/images/portal/cit_1210/53/24/181080014PDL_by_Drug_Class-Effective_2-1-12.pdf (Medicaid)
HAWAII: http://www.ohanahealthplan.com/WCAssets/hawaii/assets/OHANA_ABBREVIATED_PDL.pdf (Medicaid)
IDAHO: http://www.healthandwelfare.idaho.gov/Medical/PrescriptionDrugs/tabid/119/Default.aspx (Medicaid)
ILLINOIS: http://www.hfs.illinois.gov/assets/pdl.pdf (Medicaid)
INDIANA: http://www.indianapbm.com/Downloads/Master%20Preferred%20Drug%20List%20updated%2004-01-2011.pdf (Medicaid)
IOWA: http://www.iowamedicaidpdl.com/uploads/c4/um/c4um_T1gPjIRC_3G0QGoXw/IA_PDL_REPORT_112012.pdf (Medicaid)
KANSAS: http://www.kdheks.gov/hcf/pharmacy/download/PDLList.pdf (Medicaid)
KENTUCKY: http://kentucky.wellcare.com/WCAssets/kentucky/assets/WellCare_KY_Medicaid_PDL_tagged_approved090111.pdf (Medicaid)
LOUISIANA: http://www.lamedicaid.com/provweb1/pharmacy/preferred_08_01.htm (Medicaid)

5

MAINE: http://www.mainecarepdl.org/index.pl/pdlfiles (Medicaid)
MARYLAND: http://www.providersynergies.com/services/documents/MDM_PDL.pdf (Medicaid)
MASSACHUSETTS: https://masshealthdruglist.ehs.state.ma.us/MHDL/pubthera.do (Medicaid)
MICHIGAN: https://michigan.fhsc.com/Downloads/PDL_20120201b.pdf (Medicaid)
MINNESOTA: http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs_id_016922.pdf (Medicaid)
MISSISSIPPI: http://www.medicaid.ms.gov/Documents/Pharmacy/PDLArchive/PreferredDrugListEffective070108.pdf (Medicaid)
MISSOURI: http://dss.mo.gov/mhd/cs/pharmacy/pages/clinedit.htm - MO HealthNet is continuing to compile an extensive state-specific PDL. Therapy classes
included thus far include smoking cessation, Serotonin-Norepinephrine Reuptake Inhibitors (SNRI), Sedative Hypnotics, Psychotropic Medications, Long Acting
Narcotics (methadone), Atypical Antipsychotics, and ADHD Therapy.
MONTANA: http://medicaidprovider.hhs.mt.gov/pdf/mtuupdatedpdl02062012.pdf (Medicaid)
NEBRASKA: https://nebraska.fhsc.com/RemoteFiles/PROD/PDL/NE_PDL-20120213a.pdf (Medicaid)
NEVADA: http://www.medicaid.nv.gov/Downloads/provider/NV_PDL_20111102.pdf (Medicaid)
NEW HAMPSHIRE: http://www.dhhs.nh.gov/ombp/pharmacy/documents/preferred.pdf (Medicaid)
NEW JERSEY: http://www.americhoice.com/edocs/en/physicians/pdls/pdl_acnj.pdf (Medicaid)
NEW MEXICO: http://www.nm-formulary.com/pls/fred/fred_display_formulary.main?site_id=1 (NMRx)
NEW YORK: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf (Medicaid)
NORTH CAROLINA: http://www.ncdhhs.gov/dma/pharmacy/PDL.pdf (Medicaid & Health Choice)
NORTH DAKOTA: The North Dakota Legislature attempted to create a Medicaid PDL through a 2005 bill, SB 2284 (Sen. Krebsbach) Medicaid Prior
Authorization Program (NDMA/NDHA). The Senate defeated SB 2284 (Medicaid Preferred Drug List).
OHIO: http://jfs.ohio.gov/ohp/bhpp/PDLQuicklist.pdf (Medicaid)

6

OKLAHOMA: Oklahomans can create a login on ePocrates to view the SoonerCare drug list here: http://okhca.org/providers.aspx?id=672&menu=74.
OREGON: http://www.dhs.state.or.us/policy/healthplan/guides/pharmacy/pdl.pdf (Medicaid- Fee for-service)
PENNSYLVANIA: http://www.providersynergies.com/services/documents/PAM_PDL.pdf Medicaid)
RHODE ISLAND: http://www.dhs.ri.gov/Portals/0/Uploads/Documents/Public/Pharmacy/pdl_list.pdf (Medicaid)
SOUTH CAROLINA: http://southcarolina.fhsc.com/Downloads/provider/SCpdl_listing_20120201.pdf (Medicaid)
SOUTH DAKOTA: As of February 2012, The South Dakota Department of Social Services (DSS) is issuing this Request for Information (RFI) to solicit information,
recommendations and advice regarding a Medicaid Preferred Drug List and Supplemental Rebate program:
http://dss.sd.gov/PDL%20RFI%20DRAFT%20FINAL.2.10.pdf
TENNESSEE: https://tnm.rxportal.sxc.com/rxclaim/TNM/PDLtable.htm (Medicaid)
TEXAS: http://www.txvendordrug.com/downloads/pdl/TXMPDL_012312.pdf (Medicaid)
UTAH: http://health.utah.gov/medicaid/pharmacy/PDL/files/Utah%20Medicaid%20PDL%20021612.pdf (Medicaid)
VERMONT: http://dvha.vermont.gov/for-providers/2012-02-vt-pdl-quicklist-vt-february-7-2012-final.pdf (Medicaid)
VIRGINIA: http://www.dmas.virginia.gov/downloads/pdfs/pharm-pdl_201201_lctr.pdf (Medicaid)
WASHINGTON: http://www.rx.wa.gov/documents/washingtonpdl.pdf (Medicaid)
WEST VIRGINIA: http://www.dhhr.wv.gov/bms/Pharmacy/dur/Documents/Preferred%20Drug%20List/WV%20PDL01252012%20v2012%204a.pdf (Medicaid)
WISCONSIN: https://www.forwardhealth.wi.gov/WIPortal/Tab/42/icscontent/provider/medicaid/pharmacy/resources.htm.spage (Medicaid)
WYOMING: Wyomingites can locate the Wyoming Medicaid Formulary on ePocrates by signing up here:
http://www.health.wyo.gov/healthcarefin/pharmacy/WyomingMedicaidFormularyonEpocrates.html
DISTRICT OF COLUMBIA: https://dc.fhsc.com/downloads/providers/DCRx_PDL_listing.pdf (Medicaid)
EXAMPLES OF STATE-ONLY PDLs

7



Source Exif Data:
File Type                       : PDF
File Type Extension             : pdf
MIME Type                       : application/pdf
PDF Version                     : 1.5
Linearized                      : Yes
Tagged PDF                      : Yes
XMP Toolkit                     : Adobe XMP Core 4.0-c316 44.253921, Sun Oct 01 2006 17:14:39
Create Date                     : 2012:04:05 10:21:40Z
Creator Tool                    : Microsoft® Office Word 2007
Modify Date                     : 2012:04:05 10:22:11-06:00
Metadata Date                   : 2012:04:05 10:22:11-06:00
Producer                        : Microsoft® Office Word 2007
Format                          : application/pdf
Document ID                     : uuid:e7c7245c-8f33-4edc-b296-e2dd53a7e5f9
Instance ID                     : uuid:21c60061-1c68-4175-8946-410e00519c1b
Page Count                      : 7
Language                        : en-US
Creator                         : Microsoft® Office Word 2007
EXIF Metadata provided by EXIF.tools

Navigation menu